Ruchika Bhargav
- Infectious Diseases top 5%
- Neurology top 10%
- Oncology
- Epidemiology
- Applied Microbiology and Biotechnology top 5%
- Co-authors
- Kevin Bryan LoGrace SalacupJeri AlbanoJerald PelayoGabriel Patarroyo‐AponteZurab AzmaiparashviliJanani RangaswamiFahad Gul
- Topics
- COVID-19 Clinical Research Studies (11 papers)Long-Term Effects of COVID-19 (6 papers)Atrial Fibrillation Management and Outcomes (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of the American College of CardiologyJournal of Medical Virology
- Partner nations
- United StatesCanada
In The Last Decade
Ruchika Bhargav
15 papers receiving 448 citations
Peers
Comparison fields: 5 of 73
- Infectious Diseases 342
- Neurology 158
- Oncology 105
- Epidemiology 70
- Applied Microbiology and Biotechnology 65
Countries citing papers authored by Ruchika Bhargav
This map shows the geographic impact of Ruchika Bhargav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruchika Bhargav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruchika Bhargav more than expected).
Fields of papers citing papers by Ruchika Bhargav
This network shows the impact of papers produced by Ruchika Bhargav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruchika Bhargav. The network helps show where Ruchika Bhargav may publish in the future.
Co-authorship network of co-authors of Ruchika Bhargav
This figure shows the co-authorship network connecting the top 25 collaborators of Ruchika Bhargav. A scholar is included among the top collaborators of Ruchika Bhargav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruchika Bhargav. Ruchika Bhargav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 16 | |
| 7 | 102 | |
| 8 | 72 | |
| 9 | 8 | |
| 10 | 36 | |
| 11 | 4 | |
| 12 | 64 | |
| 13 | 23 | |
| 14 | 54 | |
| 15 | 24 | |
| 16 | 24 |
About Ruchika Bhargav
Ruchika Bhargav is a scholar working on Internal Medicine, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 16 papers that have together received 454 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (65 citations), Infectious Diseases (342 citations) and Neurology (158 citations). Ruchika Bhargav has collaborated with scholars based in United States and Canada. Frequent co-authors include Kevin Bryan Lo, Grace Salacup, Jeri Albano, Jerald Pelayo, Gabriel Patarroyo‐Aponte, Zurab Azmaiparashvili, Janani Rangaswami, Fahad Gul, Robert DeJoy and Eric Peterson. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.